Study on the platform development for therapeutics of liver disease involving liver immunobiology
碩士 === 國立陽明大學 === 生物藥學研究所 === 97 === The liver maintains in a special condition, called “tolerance”. The pathology and physiology of the liver are dependent on balance between tolerance and immunity. There are many liver diseases involving in lipopolysaccharides (LPS). The liver is the major site of...
Main Authors: | Yuan-Chi Huang, 黃元麒 |
---|---|
Other Authors: | Rong-Tsun Wu |
Format: | Others |
Language: | zh-TW |
Online Access: | http://ndltd.ncl.edu.tw/handle/56947723828479903610 |
Similar Items
-
Study on the platform development for therapeutics of liver disease
by: Yi-Jhen Li, et al.
Published: (2013) -
Proteoglycans and Immunobiology of Cancer—Therapeutic Implications
by: George Tzanakakis, et al.
Published: (2019-04-01) -
Immunobiology and Novel Therapeutics in Acute Graft-versus-Host Disease
by: Zitzer, Nina Celia
Published: (2018) -
Editorial: Immunobiology of Osteoarticular Diseases
by: Erminia Mariani, et al.
Published: (2021-05-01) -
Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets
by: Maria Sofia Basile, et al.
Published: (2019-11-01)